This report details the Specific Absorption Rate (SAR) evaluation for the NeuSpera Medical Inc. WT-1 device, a neurostimulator powering device operating in the 902MHz-912MHz frequency range. The evaluation was conducted by Bay Area Compliance Laboratories Corp. to ensure compliance with FCC regulations regarding radiofrequency radiation exposure.
The report includes a comprehensive overview of the test setup, methodology, and results. It covers system verification, tissue simulating liquid validation, and SAR measurements for various device positions. The maximum SAR levels reported are compared against FCC limits to demonstrate compliance. The document also provides detailed information on the equipment used, calibration certificates, and uncertainty analysis.
The tests were performed between February 11, 2025, and February 21, 2025, using a DASY8 measurement system. The report concludes that the NeuSpera Medical Inc. WT-1 device meets the SAR limits specified by the FCC for general population/uncontrolled exposure.
Array
(
[0] => Array
(
[url_sha] => fcf510d04402f7effcf5b98bf07afce9f8c4da51e72f2e2d5899dac603aba114
[source] => fccid
[url] => https://apps.fcc.gov/eas/GetApplicationAttachment.html?id=8308101
[href_text] => SAR Report
[href_description] => Neuspera Medical Inc. WT-002 Neurostimulator Powering Device 2BMNE-WT-002 2BMNEWT002 wt 002
[http_status] => 200
[http_lastmod] => 0000-00-00 00:00:00
[http_contenttype] =>
[http_filename] => GetApplicationAttachment.html?id=8308101
[http_size] => 3975792
[file_sha256] => 456bb1a1c96ae6f82b73e6b560860e6bb5930bbe8139dbb9ee524d46f619924e
[domain] => document.fccid
)
)
Array
(
[file_sha256] => 456bb1a1c96ae6f82b73e6b560860e6bb5930bbe8139dbb9ee524d46f619924e
[cleanFccId] => 2BMNEWT002
[title] => NeuSpera Medical Inc. SAR Evaluation Report
[description] => SAR evaluation report for the NeuSpera Medical Inc. WT-1 device, FCC ID: 2BMNE-WT-002, assessing radiofrequency exposure compliance.
[brand_name] => NeuSpera Medical Inc.
[keywords] => ["SAR Evaluation", "WT-1", "2BMNE-WT-002", "R2408161-SAR", "3297.02"]
[intro] =>
This report details the Specific Absorption Rate (SAR) evaluation for the NeuSpera Medical Inc. WT-1 device, a neurostimulator powering device operating in the 902MHz-912MHz frequency range. The evaluation was conducted by Bay Area Compliance Laboratories Corp. to ensure compliance with FCC regulations regarding radiofrequency radiation exposure.
The report includes a comprehensive overview of the test setup, methodology, and results. It covers system verification, tissue simulating liquid validation, and SAR measurements for various device positions. The maximum SAR levels reported are compared against FCC limits to demonstrate compliance. The document also provides detailed information on the equipment used, calibration certificates, and uncertainty analysis.
The tests were performed between February 11, 2025, and February 21, 2025, using a DASY8 measurement system. The report concludes that the NeuSpera Medical Inc. WT-1 device meets the SAR limits specified by the FCC for general population/uncontrolled exposure.
)
Array
(
[0] => Array
(
[id] => 8308101
[file_sha256] =>
[applicationId] => r4BN3DPg6fQa6D9VGAMKkg==
[description] => SAR Report
[shortTermConfidential] => No
[permanentConfidential] => No
[supercede] => No
[exhibitType] => RF Exposure Info
[fileType] => Adobe Acrobat PDF
[displayType] => pdf
[fileSize] => 3975792
[submissionDate] => 2025-05-20 00:00:00
[dateAvailable] => 2025-05-20 00:00:00
[creationDate] =>
[producer] =>
[modDate] =>
[title] =>
[creator] =>
[author] =>
[pages] =>
[realSize] =>
[html] => 0
[png] => 0
[txt] => 0
[version] => 1
[source] => 0
[fccId] => 2BMNE-WT-002
[cleanFccId] => 2BMNEWT002
[exif] => 0
)
)